Jackson Grant Investment Advisers’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-410
Closed -$15K 210
2017
Q4
$15K Buy
410
+7
+2% +$253 0.01% 189
2017
Q3
$15K Buy
403
+7
+2% +$255 0.01% 189
2017
Q2
$15K Buy
396
+6
+2% +$210 0.01% 166
2017
Q1
$13K Buy
390
+7
+2% +$235 0.01% 160
2016
Q4
$12K Buy
383
+14
+4% +$469 0.01% 161
2016
Q3
$13K Buy
369
+6
+2% +$212 0.01% 155
2016
Q2
$13K Buy
363
+6
+2% +$219 0.01% 150
2016
Q1
$13K Buy
357
+6
+2% +$212 0.01% 144
2015
Q4
$14K Buy
+351
New +$14.3K 0.01% 151

Other funds holding BME

Jackson Grant Investment Advisers's BME Position: Q1 2018 in Review

Jackson Grant Investment Advisers sold out of BlackRock Health Sciences Trust (BME) in Q1 2018, closing a stake of 410 shares — an estimated $15K sold.

Jackson Grant Investment Advisers first reported a position in BME in Q4 2015 and held it in 9 quarters. The position peaked at $15K in Q4 2017. 39 funds tracked by Wall St. Rank hold BME as of Q1 2018.

  • Jackson Grant Investment Advisers reported no remaining BlackRock Health Sciences Trust position as of Q1 2018 after selling out during the quarter.
  • Jackson Grant Investment Advisers sold 410 BlackRock Health Sciences Trust shares in Q1 2018, an estimated $15K.
  • Jackson Grant Investment Advisers first reported a position in BlackRock Health Sciences Trust in Q4 2015 and held it in 9 quarters.
  • Jackson Grant Investment Advisers's BlackRock Health Sciences Trust position peaked at $15K in Q4 2017.
  • 39 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2018.

Based on Jackson Grant Investment Advisers's 13F filing for Q1 2018, filed 14 May 2018.